More than 500 clinical AI algorithms have now been cleared by the FDA, with the majority just in the past couple years.

Childhood adversity alters regions of the brain responsible for processing threats, according to a new neuroimaging study. 

The data, published in Clinical Imaging, reveal that more than 20% of respondents have witnessed scientific fraud within their department and more than 85% reported the issue of publication bias. 

Results demonstrate how implementing adjusted procedures to limit radiation exposures for children may lower cancer risks and save on health care costs.

New data suggest that both obesity and Alzheimer's can cause excess grey matter cortical thinning. 

Researchers involved in the new study propose that abbreviated MRI protocols could offer more accurate assessments of liver lesions than ultrasound. 

In March of 2022, 177Lu-PSMA-617 was approved by the U.S. Food and Drug Administration for the treatment of metastatic castration-resistant prostate cancer in men with PSMA-avid disease who have previously undergone chemotherapy and a novel androgen receptor-directed therapy. 

Radiomics features could be especially useful for determining TSS in scenarios where clinical data is lacking or unreliable, such as when patients have altered mental status.